The stromal cell derived leptin is reported to support cancer metastasis in estrogen receptor positive [98] and triple negative [99] breast cancer cells by enhancing EMT via upregulating SERPINE 1, IL-6, MMP-2, SNAI 2, TWIST 1, vimentin and downregulating E-cadherin [100]. The gene discussed is LEP; the disease is breast carcinoma.